Retirement Systems of Alabama lifted its position in Steris PLC (NYSE:STE) by 45.2% during the third quarter, Holdings Channel reports. The fund owned 159,067 shares of the medical equipment provider’s stock after acquiring an additional 49,495 shares during the period. Retirement Systems of Alabama’s holdings in Steris were worth $18,197,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Steward Partners Investment Advisory LLC boosted its stake in shares of Steris by 118.0% in the third quarter. Steward Partners Investment Advisory LLC now owns 909 shares of the medical equipment provider’s stock worth $104,000 after acquiring an additional 492 shares during the last quarter. First Hawaiian Bank acquired a new stake in shares of Steris in the third quarter worth approximately $106,000. Point72 Hong Kong Ltd acquired a new stake in shares of Steris in the second quarter worth approximately $116,000. Fort L.P. acquired a new stake in shares of Steris in the second quarter worth approximately $121,000. Finally, Centaurus Financial Inc. acquired a new stake in shares of Steris in the second quarter worth approximately $184,000. 88.76% of the stock is currently owned by hedge funds and other institutional investors.
A number of analysts have recently issued reports on the company. Zacks Investment Research raised Steris from a “sell” rating to a “hold” rating in a research note on Thursday, September 27th. KeyCorp lifted their price target on Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday, August 9th. Stephens reaffirmed a “buy” rating and issued a $125.00 price target on shares of Steris in a research note on Thursday, August 9th. Finally, JMP Securities lifted their price target on Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research note on Thursday, August 9th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Steris presently has a consensus rating of “Buy” and an average price target of $100.86.
Steris (NYSE:STE) last released its quarterly earnings data on Wednesday, August 8th. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.99 by $0.01. The company had revenue of $638.76 million for the quarter, compared to analyst estimates of $638.63 million. Steris had a return on equity of 11.80% and a net margin of 11.42%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.85 earnings per share. Equities analysts anticipate that Steris PLC will post 4.71 EPS for the current year.
In other Steris news, VP Karen L. Burton sold 1,300 shares of the business’s stock in a transaction on Tuesday, August 14th. The stock was sold at an average price of $114.39, for a total transaction of $148,707.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.38% of the company’s stock.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Recommended Story: What is intrinsic value?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.